Point72 Asset Management L.P. 13D and 13G filings for Global Blood Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:46 pm Sale | 2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT | Point72 Asset Management L.P. | 225,463 0.300% | -2,999,111 (-93.01%) | Filing |
| 2021-05-13 4:34 pm Purchase | 2021-05-04 | 13G | Global Blood Therapeutics, Inc. GBT | Point72 Asset Management L.P. | 3,224,574 5.200% | 2,797,541 (+655.11%) | Filing |